Financhill
Back

Goldman Sachs Access Treasury 0-1 Year ETF Vs. Axsome Therapeutics, Inc. Industry Stock Comparison

Sell
6

GBIL
Goldman Sachs Access Treasury 0-1 Year ETF

Last Price:
$99.94
Seasonality Move:
0.01%
Buy
75

AXSM
Axsome Therapeutics, Inc.

Last Price:
$182.74
Seasonality Move:
22.61%
Sell
6
Goldman Sachs Access Treasury 0-1 Year ETF (GBIL) is a Sell

Is Goldman Sachs Access Treasury 0-1 Year ETF a Buy, Sell or Hold?

  • The current Goldman Sachs Access Treasury 0-1 Year ETF [GBIL] share price is $99.94. The Score for GBIL is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • GBIL is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
75
Axsome Therapeutics, Inc. (AXSM) is a Buy

Is Axsome Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Axsome Therapeutics, Inc. [AXSM] share price is $182.64. The Score for AXSM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • AXSM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GBIL Stock Price Chart

What is Goldman Sachs Access Treasury 0-1 Year ETF's stock price today?

AXSM Stock Price Chart

What is Axsome Therapeutics, Inc.'s stock price today?

  • The Axsome Therapeutics, Inc. share price today is $182.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing buying pressure, which is a positive indicator for future bullish movement.

GBIL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 34.08 Sell
Chaikin Money Flow: 600701 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100 - 100.2) Sell
Bollinger Bands (100): (99.98 - 100.16) Sell

AXSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.73 Buy
Relative Strength Index (14 RSI): 79.74 Buy
Chaikin Money Flow: 2638953 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (143.49 - 157.75) Buy
Bollinger Bands (100): (116.98 - 146.48) Buy

GBIL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 100.17 Sell
20-day SMA: 100.09 Sell
50-day SMA: 100.08 Sell
200-day SMA: 100.04 Sell
8-day EMA: 100.14 Sell
20-day EMA: 100.12 Sell
50-day EMA: 98.71 Buy
200-day EMA: 65.75 Buy

AXSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 156.17 Buy
20-day SMA: 151.07 Buy
50-day SMA: 144.32 Buy
200-day SMA: 119.69 Buy
8-day EMA: 157.9 Buy
20-day EMA: 152.42 Buy
50-day EMA: 144.44 Buy
200-day EMA: 123.72 Buy

Goldman Sachs Access Treasury 0-1 Year ETF Earnings Growth & GBIL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Axsome Therapeutics, Inc. Earnings Growth & AXSM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.11 per share, and an increase next year of $5.92 per share.

Goldman Sachs Access Treasury 0-1 Year ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Axsome Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):